Background: Patients with hematological malignancies admitted to an intensive care
admission.
14 Severity of illness was mainly reflected by higher organ failure scores and the need for mechanical ventilation and vasopressors. This associated poor outcome sometimes results in reluctance to admit this subgroup of patients to the ICU. More recent studies however show a better survival after ICU admission and, even more important, that the long-term health-related quality of life (HRQoL) is not affected. 11, 15, 16 It is difficult to predict a patient's prognosis based solely on parameters that are available at ICU admission. For this reason, less restrictive admission policies have been advocated, often resulting in a trial of ICU admission and treatment, during which unlimited care is provided for a limited period of time. 17, 18 After an arbitrary period of 3-7 days, a decision is then made whether or not to continue ICU treatment. Consequently, after a few days of ICU treatment there is a need for parameters which contribute to evaluate the prognosis at that time. For this purpose, changes in organ failure scores, such as the Sequential Organ Failure Assessment (SOFA) score 19 (Table 1) , during ICU stay have been studied. 3, 10, 20 The SOFA score was initially designed to study organ failure in patients with sepsis (sepsis-related organ failure assessment) admitted to the intensive care unit, using six categories (see Materials and Methods). As the score was not specific for sepsis, it was later changed into the Sequential Organ Failure Assessment. A recent study developed a modified hematological SOFA score taking into account recent infection before admission, and this modified score was better for discriminating survivors from non-survivors than the unmodified score. 21 For several reasons, we hypothesize that the conventional SOFA score is not a good reflection of the current problem that caused the transfer to the ICU. First, as platelets are an important part of the SOFA score, it can be envisaged that the thrombocytopenia in patients with a hematological malignancy admitted to the ICU is an expression of the underlying hematological disease rather than a reflection of the current problem. Second, recent studies evaluated a modified SOFA score in medical and surgical patients, omitting the neurological score and showed this score was significantly associated with mortality.
22,23
The neurological score was excluded as the results of the neurological evaluation are most commonly influenced by the use of sedatives. The recent study in hematological patients only calculated the modified score on admission and because of that we did not involve this score. 21 In the present study, the classical SOFA score was consequently changed into the modified hematological SOFA score (SOFA hem ), omitting the coagulation and central nervous system parameters (Table 1) , and furthermore the trend in SOFA was studied in a larger cohort because the study of Geerse et al. 10 suggested that the change in SOFA score during the stay on the ICU could be helpful in decision-making about further treatment. We also studied the trend in SOFA hem .
| MATERIALS AND METHODS
All patients with hematological malignancies that were admitted to the ICU of the Maastricht University Medical Center (MUMC) in Maastricht, the Netherlands, were retrospectively included between December 1999 and November 2009. A cohort of patients previously studied was part of this population. 10 All hematological patients who were transferred from the hematology ward to the ICU or hematological patients who were directly admitted to the ICU through the emergency department were identified. Readmissions were not evaluated.
Decisions to admit a patient to the ICU were made together by the intensivists and hematologists. Because of the retrospective design of the study, approval of the study, by the institutional review board (IRB), was not needed. The SOFA hem score was defined as the sum of the four components omitting the coagulation and neurological parameters.
Patients were grouped based on trend in SOFA and SOFA hem score 
| RESULTS
In this study, 174 admissions were seen in 149 different patients.
Of these, 75 patients (86 admissions) were previously described in the study of Geerse et al. 10 Nineteen patients were readmitted once, three were readmitted twice. Of those patients, only the first admission was evaluated. Acute myeloid leukemia was the most common hematological malignancy diagnosed (40%), followed by non-Hodgkin lymphoma (31%).
In 101 patients (68%), chemotherapy was administered within 30 days prior to ICU admission and 60 patients (40%) had undergone a stem cell transplantation and the majority (60%), an allogeneic transplantation. Neutropenia at ICU admission was seen in 84 patients (56%). The most common indications for ICU admission were respiratory insufficiency (47% of patients) and sepsis (26% of patients). Mean APACHE II score was 29.5±7.4, and mean SOFA score at admission was 10.9±3.4.
Ninety-eight patients (66%) were mechanically ventilated and 99 patients (66%) received vasopressor or inotropic therapy within 24 hours after ICU admission.
Differences in ICU survivors and non-survivors are displayed in neither did the presence and duration of neutropenia, neutropenia recovery on the ICU, and the presence of graft-vs -host disease.
SOFA scores were available on day 1 and day 3 for 103 patients.
The trend in SOFA and SOFA hem is shown in Table 3 . Patients with an unchanged or increased SOFA score had a higher ICU mortality (57 resp. 55%) as compared to patients with a decreased SOFA score (30%). For the patient group with an increased score, this difference was not significant, and for the patients with an unchanged score, it was significant. The SOFA hem showed that patients with an increased score had the highest mortality (67%), but patients with an unchanged SOFA hem score also had a significantly worse outcome (53%) than patients with a decreased SOFA hem score (25%, Table 3 ). Table 4 shows the univariable logistic regression analysis of factors associated with ICU mortality. Patients without the history of a stem cell transplantation and patients with an allogeneic stem cell transplantation had significantly higher ICU mortality compared to autologous transplantation. The APACHE II score, the SOFA score at admission and an unchanged SOFA score, and an increased or an unchanged SOFA hem score were also significantly associated with ICU mortality.
Furthermore, mechanical ventilation, cardiopulmonary resuscitation, and the need for vasopressor/inotropic therapy were associated with worse outcome.
As described before, the trend in SOFA and SOFA hem score was corrected separately for invasive mechanical ventilation, vasopressor/ inotropic therapy, and APACHE II. Patients with an unchanged or increased SOFA score had a significant worse outcome than patients with a decreased SOFA score, only when correcting for vasopressor/ inotropic medication an increasing score did not show significance.
The trend in SOFA hem score was independently associated with mortality ( Table 5) . In this analysis, the classical and modified score were both associated with poor patient outcome, but the odds ratios for the SOFA hem score were higher and the P-values lower.
| DISCUSSION
Whereas most previous studies on the prognosis of hematology patients at the ICU only reported on the predictive value of parameters available on ICU admission, the current study also evaluated prognostic parameters after 3 days of ICU treatment using the classical and a modified SOFA score. The main findings of the present study are consecutively discussed in the sections below.
Our findings confirm that the prognosis in hematological patients is primarily determined by severity of illness, rather than underlying disease specific characteristics. 3, 24, 25 In this study, mortality was also associated with higher organ failure scores on admission, as well as inotropic/vasopressor therapy and mechanical ventilation. Although some studies reported that disease characteristics were not associated with ICU mortality, other studies reported a poor prognosis in patients after allogeneic SCT, 5, 26, 27 In the present study, a higher mortality was seen in patients who had received an allogeneic SCT prior to ICU admission. This subgroup of patients represented only a minority (24%) of our population, as was the case in other studies.
Patients without a stem cell transplantation compared to patients with an autologous stem cell transplantation also had a worse outcome. This group reflects the patients with acute leukemia, who have a higher mortality rate than patients without leukemia. Some prior studies also described an association between acute myeloid leukemia (AML) and a worse outcome. 28 Trend: decreased or increased was defined as ≥2 points change compared to the admission SOFA/ SOFA hem score and the SOFA/SOFA hem score on day 3; n.s., non-significant; ICU, intensive care unit; SOFA, sequential organ failure assessment.
T A B L E 3 Effect of trend in SOFA and SOFA hem score on ICU mortality 
T A B L E 4 Univariable analysis of factors associated with ICU mortality
In line with most other studies, no difference in mortality in patients with neutropenia or patients with neutropenia recovery during ICU stay was seen. Some studies, although, did find higher mortality in patients with neutropenia or neutropenia recovery at the ICU. 30, 31 Furthermore, the change in SOFA score offers important additional prognostic information to help in this decision-making process to continue or discontinue treatment during such an ICU trial. 3, 8, 10 Patients with a deterioration of SOFA or SOFA hem score have a poor prognosis, and the trend in SOFA and SOFA hem score is independently related to mortality in our population of hematological patients admitted to the ICU.
The observation that the odds ratios for the SOFA hem score are higher than for the SOFA score in the multivariable analysis and the P-values are lower even supports our view that the SOFA hem score was stronger related with mortality than the classical SOFA score. In hematological patients, neither the coagulation nor the neurological parameters are thus contributive because thrombocytopenia does not have to be an expression of the severity of illness, but is likely to be at least partly, an expression of the underlying hematological disease.
The conclusions of other studies that the neurological component can also be omitted were confirmed in this patient group. 22, 23 Despite the improvement in predictive power using the SOFA hem score compared to the traditional SOFA score, the trend in SOFA hem score is however still not an absolute decisive factor whether to continue treatment or not, as even in the poor risk group with an increasing SOFA hem score, about 30% of the patients survive their intensive care stay. However, the trend in SOFA hem score can aid in decision-making, taking into account all other clinically relevant information, and seems to perform better than the traditional SOFA in this respect.
| LIMITATIONS
This study has some limitations. First, this is a retrospective single center study. Admission policies and decision-making regarding resuscitation may be center specific, so patient characteristics in our population may differ from other centers. This may decrease the generalizability of our findings.
Second, in a significant number of patients (46/149), data to calculate the SOFA hem score on day 3 were not available, either due to missing results, death of the patients, or discharge to the ward before a second SOFA score could be determined. Therefore, the SOFA trend could not be analyzed for all included patients.
Third, our population included patients with a mix of different hematological diseases. Conclusions may be different for certain subgroups. These subgroups were too small to perform multivariable analysis.
| CONCLUSIONS
In patients with hematological malignancies admitted to the ICU, trends in SOFA or SOFA hem score are both suitable as prognostic parameters that could aid in decision-making regarding continuation of care. In this study, an unchanged or increased SOFA hem and unchanged SOFA score between days 1 and 3 is independently associated with mortality in ICU patients with hematological malignancies. The trend in the modified hematological SOFA score omitting the neurological and hematological component probably is stronger related to mortality compared to the classical score and can be used in daily practice. It seems promising as an independent predictor of T A B L E 5 Multivariable logistic regression analyses for trend in SOFA hem and SOFA score corrected for consecutively APACHE, invasive mechanical ventilation (MV), and vasopressor/inotropic medication (INO) 
